Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent.
Am Heart J
; 231: 147-156, 2021 01.
Article
in En
| MEDLINE
| ID: mdl-33031789
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Platelet Aggregation Inhibitors
/
Aspirin
/
Acute Coronary Syndrome
/
Drug-Eluting Stents
/
Purinergic P2Y Receptor Antagonists
/
Everolimus
/
Immunosuppressive Agents
/
Myocardial Infarction
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Am Heart J
Year:
2021
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
United States